{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:38:09Z","timestamp":1792643889373,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lipidjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jacl.2026.09.026","type":"journal-article","created":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T14:20:31Z","timestamp":1791123631000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association of serum complement levels with failure of low-density-lipoprotein-cholesterol target attainment in patients after acute coronary syndrome: A prospective, observational study"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1156-996X","authenticated-orcid":false,"given":"Vasileios","family":"Gogolas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9585-517X","authenticated-orcid":false,"given":"Evdoxia","family":"Kyriazopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Dagre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8241-7886","authenticated-orcid":false,"given":"Ignatios","family":"Ikonomidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3096-3791","authenticated-orcid":false,"given":"Christoforos","family":"Olympios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerasimos","family":"Filippatos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Alexopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7349-0309","authenticated-orcid":false,"given":"Loukianos S.","family":"Rallidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacl.2026.09.026_bib1","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1161\/CIR.0000000000000558","article-title":"Heart disease and stroke statistics-2018 update: a report from the American Heart Association","volume":"137","author":"Benjamin","year":"2018","journal-title":"Circulation"},{"issue":"23 1","key":"10.1016\/j.jacl.2026.09.026_bib2","first-page":"III20","article-title":"Inflammation in atherosclerosis and implications for therapy","volume":"109","author":"Paoletti","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2026.09.026_bib3","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1161\/hc0902.104353","article-title":"Inflammation and atherosclerosis","volume":"105","author":"Libby","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2026.09.026_bib4","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/ni.2001","article-title":"The immune system in atherosclerosis","volume":"12","author":"Hansson","year":"2011","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jacl.2026.09.026_bib5","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacl.2026.09.026_bib6","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"Evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacl.2026.09.026_bib7","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1056\/NEJMoa1801174","article-title":"Alirocumab and cardiovascular outcomes after acute coronary syndrome","volume":"379","author":"Schwartz","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacl.2026.09.026_bib8","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa1410489","article-title":"Ezetimibe added to statin therapy after acute coronary syndromes","volume":"372","author":"Cannon","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacl.2026.09.026_bib9","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1177\/2047487317708677","article-title":"Early, intensive statin treatment reduces 'hard' cardiovascular outcomes after acute coronary syndrome","volume":"24","author":"Schwartz","year":"2017","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.jacl.2026.09.026_bib10","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/j.jacc.2005.03.077","article-title":"Early and late benefits of high-dose atorvastatin in patients with acute coronary syndromes: results from the PROVE IT-TIMI 22 trial","volume":"46","author":"Ray","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacl.2026.09.026_bib11","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.jacc.2016.11.070","article-title":"Atherothrombotic risk stratification and ezetimibe for secondary prevention","volume":"69","author":"Bohula","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacl.2026.09.026_bib12","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s00392-019-01511-0","article-title":"Residual inflammatory risk in coronary heart disease: incidence of elevated high-sensitive CRP in a real-world cohort","volume":"109","author":"Peikert","year":"2020","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.jacl.2026.09.026_bib13","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0162-3109(99)00007-7","article-title":"Regulation of complement activation by C-reactive protein","volume":"42","author":"Mold","year":"1999","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.jacl.2026.09.026_bib14","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/eurheartj\/ehy462","article-title":"Fourth universal definition of myocardial infarction (2018)","volume":"40","author":"Thygesen","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacl.2026.09.026_bib15","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","article-title":"2023 ESC guidelines for the management of acute coronary syndromes","volume":"44","author":"Byrne","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacl.2026.09.026_bib16","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin Chem"},{"key":"10.1016\/j.jacl.2026.09.026_bib17","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ejim.2006.07.031","article-title":"Acute phase proteins in patients with acute coronary syndrome: correlations with diagnosis, clinical features, and angiographic findings","volume":"18","author":"Brunetti","year":"2007","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.jacl.2026.09.026_bib18","first-page":"515","article-title":"[Dynamic changes of complement level in patients with acute coronary syndrome and its relationships with myocardial injury]","volume":"29","author":"Shao","year":"2017","journal-title":"Zhonghua Wei Zhong Bing Ji Jiu Yi Xue"},{"key":"10.1016\/j.jacl.2026.09.026_bib19","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.jacl.2021.01.011","article-title":"C3 and alternative pathway components are associated with an adverse lipoprotein subclass profile: the CODAM study","volume":"15","author":"Xin","year":"2021","journal-title":"J Clin Lipidol"},{"issue":"3","key":"10.1016\/j.jacl.2026.09.026_bib20","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1538-7836.2010.04172.x","article-title":"Complement in atherosclerosis: friend or foe?","volume":"9","author":"Speidl","year":"2011","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jacl.2026.09.026_bib21","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.atherosclerosis.2004.07.022","article-title":"Association of high serum concentration of the third component of complement (C3) with pre-existing severe coronary artery disease and new vascular events in women","volume":"177","author":"Sz\u00e9plaki","year":"2004","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2026.09.026_bib22","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.atherosclerosis.2008.07.007","article-title":"Complement C3 and C-reactive protein in male survivors of myocardial infarction","volume":"203","author":"Carter","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2026.09.026_bib23","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1161\/01.CIR.0000087447.12918.85","article-title":"Pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to primary percutaneous coronary intervention in acute myocardial infarction: the Complement Inhibition in Myocardial Infarction Treated With Angioplasty (COMMA) trial","volume":"108","author":"Granger","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2026.09.026_bib24","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1001\/jama.291.19.2319","article-title":"Terminal complement blockade with pexelizumab during coronary artery bypass graft surgery requiring cardiopulmonary bypass: a randomized trial","volume":"291","author":"Verrier","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.jacl.2026.09.026_bib25","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1001\/jama.297.1.43","article-title":"Pexelizumab for acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention: a randomized controlled trial","volume":"297","author":"Armstrong","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.jacl.2026.09.026_bib26","first-page":"20","article-title":"Real-world management of hypercholesterolemia in patients after acute coronary syndrome in Greece","volume":"60","author":"Massia","year":"2025","journal-title":"Atheroscler"},{"key":"10.1016\/j.jacl.2026.09.026_bib27","doi-asserted-by":"crossref","DOI":"10.1186\/s13059-014-0460-9","article-title":"Prediction of LDL cholesterol response to statin using transcriptomic and genetic variation","volume":"15","author":"Kim","year":"2014","journal-title":"Genome Biol"},{"key":"10.1016\/j.jacl.2026.09.026_bib28","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.019525","article-title":"Circulating mature PCSK9 level predicts diminished response to statin therapy","volume":"10","author":"Kuyama","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacl.2026.09.026_bib29","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1476-511X-10-48","article-title":"Apolipoprotein E epsilon-4 polymorphism is associated with younger age at referral to a lipidology clinic and a poorer response to lipid-lowering therapy","volume":"10","author":"Baptista","year":"2011","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.jacl.2026.09.026_bib30","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jacl.2013.03.007","volume":"7","author":"Robinson","year":"2013","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2026.09.026_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.chemphyslip.2023.105348","article-title":"Lipidomic analysis identified potential predictive biomarkers of statin response in subjects with Familial hypercholesterolemia","volume":"257","author":"Cerda","year":"2023","journal-title":"Chem Phys Lipids"},{"key":"10.1016\/j.jacl.2026.09.026_bib32","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1021\/pr501277g","article-title":"Systematic investigation of cellular response and pleiotropic effects in atorvastatin-treated liver cells by MS-based proteomics","volume":"14","author":"Xiao","year":"2015","journal-title":"J Proteome Res"},{"key":"10.1016\/j.jacl.2026.09.026_bib33","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1007\/s00134-018-5378-3","article-title":"Latent class analysis of ARDS subphenotypes: a secondary analysis of the statins for acutely injured lungs from sepsis (SAILS) study","volume":"44","author":"Sinha","year":"2018","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jacl.2026.09.026_bib34","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S2213-2600(18)30177-2","article-title":"Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: secondary analysis of a randomised controlled trial","volume":"6","author":"Calfee","year":"2018","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jacl.2026.09.026_bib35","doi-asserted-by":"crossref","DOI":"10.1186\/s13054-022-04055-4","article-title":"Effect of intravenous clarithromycin in patients with sepsis, respiratory and multiple organ dysfunction syndrome: a randomized clinical trial","volume":"26","author":"Karakike","year":"2022","journal-title":"Crit Care"},{"key":"10.1016\/j.jacl.2026.09.026_bib36","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.molimm.2015.02.027","article-title":"The role of complement factor C3 in lipid metabolism","volume":"67","author":"Barbu","year":"2015","journal-title":"Mol Immunol"},{"key":"10.1016\/j.jacl.2026.09.026_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1511886","article-title":"The complement system in lipid-mediated pathologies","volume":"15","author":"Alic","year":"2024","journal-title":"Front Immunol"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287426005428?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287426005428?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T03:48:20Z","timestamp":1792640900000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287426005428"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":37,"alternative-id":["S1933287426005428"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2026.09.026","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of serum complement levels with failure of low-density-lipoprotein-cholesterol target attainment in patients after acute coronary syndrome: A prospective, observational study","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2026.09.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 National Lipid Association. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}